PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China flag China · Delayed Price · Currency is CNY
36.71
-0.89 (-2.37%)
Mar 19, 2026, 3:04 PM CST
Market Cap8.76B +6.0%
Revenue (ttm)1.98B +26.8%
Net Income201.14M +14.9%
EPS1.00 +14.5%
Shares Out232.97M
PE Ratio37.63
Forward PE49.47
Dividend0.28 (0.74%)
Ex-Dividend DateMay 30, 2025
Volume4,875,300
Average Volume5,690,543
Open37.64
Previous Close37.60
Day's Range36.54 - 37.64
52-Week Range27.07 - 53.54
Beta0.65
RSI36.17
Earnings DateApr 22, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small... [Read more]

Sector Healthcare
Founded 2006
Employees 2,455
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300725
Full Company Profile

Financial Performance

In 2024, SHE:300725's revenue was 1.69 billion, a decrease of -2.12% compared to the previous year's 1.73 billion. Earnings were 219.54 million, an increase of 11.24%.

Financial Statements